Worth Venture Partners’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,673
| Closed | -$201K | – | 133 |
|
|
2020
Q2 | $201K | Sell |
4,673
-1,904
| -29% | -$81.9K | 0.1% | 84 |
|
|
2020
Q1 | $237K | Buy |
6,577
+1,066
| +19% | +$38.4K | 0.15% | 63 |
|
|
2019
Q4 | $252K | Sell |
5,511
-703
| -11% | -$32.1K | 0.12% | 64 |
|
|
2019
Q3 | $221K | Sell |
6,214
-797
| -11% | -$28.3K | 0.13% | 67 |
|
|
2019
Q2 | $279K | Sell |
7,011
-1,624
| -19% | -$64.6K | 0.15% | 56 |
|
|
2019
Q1 | $359K | Buy |
8,635
+133
| +2% | +$5.53K | 0.2% | 56 |
|
|
2018
Q4 | $310K | Buy |
8,502
+3,871
| +84% | +$141K | 0.23% | 54 |
|
|
2018
Q3 | $25K | Buy |
+4,631
| New | +$25K | 0.02% | 130 |
|
|
2018
Q1 | – | Sell |
-5,191
| Closed | -$226K | – | 105 |
|
|
2017
Q4 | $226K | Buy |
+5,191
| New | +$226K | 0.25% | 65 |
|
|
2017
Q2 | – | Sell |
-6,469
| Closed | -$271K | – | 122 |
|
|
2017
Q1 | $271K | Buy |
+6,469
| New | +$271K | 0.24% | 82 |
|